ArticleCase reports in obstetrics and gynecology2026
Living Newborn Back-To-Back With a Complete Hydatidiform Mole: A Rare Twin Pregnancy Outcome.
Article in Case reports in obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Living Newborn Back-To-Back With a Complete Hydatidiform Mole: A Rare Twin Pregnancy Outcome.Case reports in obstetrics and gynecology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Twin pregnancy with complete hydatidiform mole (CHM) management is challenging and remains unguided up to this date. This report presents the case of a 20-year-old woman that was diagnosed with CHM coexisting with a healthy fetus at 18 week of gestation, following presentation with an episode of vaginal bleeding. After rigorous counseling about the significantly high risks of obstetrical complications and gestational trophoblastic neoplasia (GTN), the patient declined termination. Luckily, pregnancy was uncomplicated and successfully brought up to 34 weeks of gestation with serial follow-ups, leading to an uncomplicated delivery via cesarean section. This condition presents unique diagnostic and management challenges, as clinicians must balance the potential for fetal survival against significant maternal risks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.